Monographs: Pharmaceutical substances: Betamethasone (Betamethasonum)Molecular formula. C22H29FO5 Relative molecular mass. 392.5 Graphic formula. Chemical name. 9-Fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione; CAS Reg. No. 378-44-9. Description. A white or creamy white powder; odourless. Solubility. Practically insoluble in water; sparingly soluble in ethanol (~750 g/l) TS. Category. Adrenoglucocorticoid. Storage. Betamethasone should be kept in a tightly closed container, protected from light. Requirements Definition. Betamethasone contains not less than 96.0% and not more than 104.0% of C22H29FO5 calculated with reference to the dried substance. Identity tests • Either tests A, B and C, or tests B, C and D may be applied.
Specific optical rotation. Use a 5.0 mg/mL solution in dioxan R; Sulfated ash. Weigh 0.1 g and use a platinum dish; not more than 5.0 mg/g. Loss on drying. Dry to constant weight at 100°C under reduced pressure (not exceeding 0.6 kPa or about 5 mm of mercury); it loses not more than 5.0 mg/g. Related steroids. Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography, using silica gel R1 as the coating substance and a mixture of 77 volumes of dichloromethane R, 15 volumes of ether R, 8 volumes of methanol R, and 1.2 volumes of water as the mobile phase. Apply separately to the plate 1 μl of each of 2 solutions in a mixture of 9 volumes of chloroform R and 1 volume of methanol R containing (A) 15 mg of the test substance per mL and (B) 15 mg of betamethasone RS per mL; also apply to the plate 2 μl of a third solution (C) composed of a mixture of equal volumes of solutions A and B and 1μl of a fourth solution (D) containing 0.15 mg of the test substance per mL in the same solvent mixture used for solutions A and B. After removing the plate from the chromatographic chamber, allow it to dry in air until the solvents have evaporated and heat at 105°C for 10 minutes, allow to cool, spray with blue tetrazolium/sodium hydroxide TS, and examine the chromatogram in daylight. Any spot obtained with solution A, other than the principal spot, is not more intense than that obtained with solution D. Assay. • The solutions must be protected from light throughout the assay. Dissolve about 20 mg, accurately weighed, in sufficient aldehyde-free ethanol (~750 g/l) TS to produce 100 mL. Dilute 20 mL of this solution with sufficient aldehyde-free ethanol (~750 g/l)TS to produce 100 mL. Transfer 10.0 mL of the diluted solution to a 25-mL volumetric flask, add 2.0 mL of blue tetrazolium/ethanol TS, and displace the air in the flask with oxygen-free nitrogen R. Immediately add 2.0 mL of tetramethylammonium hydroxide/ethanol TS and again displace the air with oxygen-free nitrogen R. Stopper the flask, mix the contents by gentle swirling and allow to stand for 1 hour in a water-bath at 30°C. Cool rapidly, add sufficient aldehyde-free ethanol (~750 g/l) TS to produce 25 mL and mix. Measure the absorbance of a 1-cm layer at the maximum at about 525 nm against a solvent cell containing a solution prepared by treating 10 mL of aldehyde-free ethanol (~750 g/l) in a similar manner. Calculate the amount of C22H29FO5 in the substance being tested by comparison with betamethasone RS, similarly and concurrently examined.
|